Head-to-head comparisons of medication uses, side effects, warnings, and more.
Breo ellipta (fluticasone / vilanterol)
Symbicort (budesonide / formoterol)
Breo ellipta (fluticasone / vilanterol)
Symbicort (budesonide / formoterol)
Summary of Breo Ellipta vs. Symbicort
Summary for ICS / LABA combo
Prescription only
Breo is a combination inhaler used for maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma in adults and children. It contains two active ingredients, fluticasone (an inhaled corticosteroid, or ICS) and vilanterol (a long-acting beta agonist, or LABA). Breo Ellipta (fluticasone / vilanterol) is inhaled through the mouth once per day. It's available as a lower-cost generic. Side effects can differ based on your age and your Breo Ellipta (fluticasone / vilanterol) dose, but generally include upper respiratory tract infections, sore throat, and headache.
Summary for IC / LABA
Prescription only
Symbicort (budesonide / formoterol) is a combination inhaler containing a steroid (budesonide) and a long-acting beta-agonist (formoterol). Both medications work together to treat asthma and chronic obstructive pulmonary disease (COPD). The typical dose for Symbicort (budesonide / formoterol) is 2 inhalations by mouth twice a day, about 12 hours apart. Common side effects include symptoms of common cold, such as stuffy nose and cough. It's available in two different strengths, both with generic versions.